{
  "guideline": {
    "id": "PA166104955",
    "name": "Annotation of DPWG Guideline for hormonal contraceptives for systemic use and F5",
    "source": "DPWG",
    "version": 28,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104955",
    "relatedChemicals": [
      {
        "id": "PA452637",
        "name": "hormonal contraceptives for systemic use",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA159",
        "name": "coagulation factor V",
        "symbol": "F5"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166299207",
      "name": "Recommendation PA166299207",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA452637",
          "name": "hormonal contraceptives for systemic use",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061570,
        "html": "<p>If the patient has a FAMILY HISTORY WITH A LOT OF THROMBOSIS, or has had a PREVIOUS THROMBOSIS:</p>\n<ol>\n<li>Advise the prescriber to avoid the use of contraceptives that contain oestrogens and prescribe a non-hormone contraceptive - such as a copper IUD - as an\nalternative. One could also opt for a progestogen-only contraceptive method, such as the depot injection, an IUD with levonorgestrel or an implant with etonogestrel.<br />\nOTHER CASES:</li>\n<li>Advise the patient to avoid additional risk factors for thrombosis (obesity, smoking, etc.).</li>\n</ol>\n"
      },
      "implications": [
        "The homozygously present genetic polymorphism “factor V Leiden” causes an increased tendency to coagulation, resulting in an increased risk of venous thromboembolism.\nContraceptives containing oestrogens can increase this risk even further."
      ],
      "lookupKey": {
        "F5": "Factor V Leiden homozygous"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166299206",
      "name": "Recommendation PA166299206",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA452637",
          "name": "hormonal contraceptives for systemic use",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061569,
        "html": "<p>The guideline does not provide a recommendation for estrogen-containing contraceptives in patients who do not have the Factor V Leiden variant.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of the absence of Factor V Leiden on estrogen-containing contraceptives."
      ],
      "lookupKey": {
        "F5": "Factor V Leiden absent"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166299205",
      "name": "Recommendation PA166299205",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA452637",
          "name": "hormonal contraceptives for systemic use",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061568,
        "html": "<p>If the patient has a FAMILY HISTORY WITH A LOT OF THROMBOSIS, or has had a PREVIOUS THROMBOSIS:</p>\n<ol>\n<li>Advise the prescriber to avoid the use of contraceptives that contain oestrogens and prescribe a non-hormone contraceptive - such as a copper IUD - as an\nalternative. One could also opt for a progestogen-only contraceptive method, such as the depot injection, an IUD with levonorgestrel or an implant with etonogestrel.<br />\nOTHER CASES:</li>\n<li>Advise the patient to avoid additional risk factors for thrombosis (obesity, smoking, etc.).</li>\n</ol>\n"
      },
      "implications": [
        "The heterozygously present genetic polymorphism “factor V Leiden” causes an increased tendency to coagulation, resulting in an increased risk of venous thromboembolism.\n\nContraceptives containing oestrogens can increase this risk even further."
      ],
      "lookupKey": {
        "F5": "Factor V Leiden heterozygous"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": true
    }
  ],
  "citations": [
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232"
    }
  ],
  "version": "2024-02-29-20-19"
}